Connect with us

Cannabis News

Three In Four American Voters Want Hemp To Stay Legal, With Enhanced Regulations, Poll Finds

Published

7 months ago

on

American voters across the political spectrum support legalizing consumer hemp products and enacting regulations to ensure public safety and prevent youth access, according to a new poll.

The McLaughlin & Associates survey, commissioned by the Hemp Industry & Farmers of America (HIFA), comes amid heightened debate in Congress and state legislatures across the country on how to navigate consumer hemp product laws, which were made federally legal under the 2018 Farm Bill signed into law by President Donald Trump in his first term.

Overall, 72 percent of respondents said they want to see hemp retain its legal status under federal law, with “new safety and licensing regulations.” Notably, Republicans were 77 percent in favor, compared to Democrats (71 percent) and independents (68 percent).

The question to voters did not ask about hemp being legal, so it’s unclear what percentage is falling back or being affected by the addition of new regulations. He asked, “Would you support or oppose a federal law to continue to allow the sale and possession of hemp-based consumer products with new safety and licensing regulations to protect children and adult consumers, including age restrictions for adult-only use, free school zones, and greater transparency such as clear health and warning labels.”

Given their generally popular regulatory policies, it is not surprising that strong majorities in both parties expressed support for a legal framework for the cultivation of cannabis.

When asked individually about specific regulatory proposals, 87 percent said they want child-friendly packaging, 86 percent want to limit sales to adults over 21, 81 percent said there should be marketing restrictions to prevent appeal to youth, and 71 percent said hemp products should not contain “unnatural psychoactive substances.”

The survey “shows strong support for passing federal legislation to continue to allow the sale and possession of hemp-based consumer products with new common-sense safety rules,” a survey release said.

Additionally, polls show that 55 percent of respondents who voted to keep hemp’s legal status would be more likely to support a political candidate with improved regulations. It includes 62% of Republicans, 53% of Democrats and 48% of independents.

“The hemp ban is a harmful government overreach, plain and simple,” HIFA Executive Director Brian Swensen said in a press release. “The desire to ban or regulate farmers and small business owners puts hundreds of thousands of jobs at risk, and Americans across the political spectrum.”

“After nearly a decade of law-abiding farmers and companies investing in this industry, changing the rules now would be a slap in the face,” he said. “Congress should think twice and work with the hemp industry to support common sense regulations instead of passing retroactive bans that penalize responsible operators.”

According to the survey, nearly half (47 percent) of voters have personally purchased hemp products or know someone who has.

Survey first notify On the part of the city council, there were interviews with 1,000 voters between October 1 and 5, with a margin of error of +/-3.1 points.

Last week, a major hemp industry organization sent a letter to Trump praising him for his role in legalizing the crop during his first term and banning hemp products by asking Congress to avoid “delaying” reform containing any amount of THC.

“As hemp growers, farmers, consumers and advocates, we are grateful and remain hopeful that your influence can save the $28.4 billion hemp industry you helped make possible,” the US Hemp Board said. “Your recent video sharing about the extraordinary value of hemp products was important in raising awareness of the positive impact of our products grown and manufactured in the United States.”

That was a reference to the president’s recent sharing of a video from The Commonwealth Project He touted the health benefits of hemp-derived CBD, especially for the elderly.

“Congress is close to passing a hemp ban, reversing the work you led to make hemp boom in 2018,” he said. “The proposed change in the definition of hemp, which says that Americans are protected, would eliminate 95 percent of this American industry that you are so proud of.”

—
It’s Marijuana Moment tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25 a month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Lawmakers from both sides of Congress have raised similar concerns in a recent letter to House Speaker Mike Johnson (R-LA) pushing back against attempts to ban THC hemp products. That was argued by the members such a change in policy will “deal a fatal blow” to the industry. and, as currently contained in a spending bill, violates congressional rules. For this purpose, the members say that there is an intention to implement an alternative measure to regulate the market.

At the federal level, on the other hand The Senate eventually removed the hemp THC ban language from its version After a procedural protest from Sen. Rand Paul (R-KY) over the farm spending measure, there is still concern among stakeholders that it could end up in the final package sent to the president after bicameral negotiations.

Meanwhile, Democratic senators also sent a letter to the administration last month He warned of major upheavals in the hemp market If products containing any amount of THC were to be banned.

Dozens of Kentucky hemp farmers also recently petitioned senior U.S. Senator McConnell. he backtracked on his push to re-criminalize some crop-derived products.

Paul, for his part, recently noted this The cannabis policy movement has ‘pushed hard for prohibition’ amid controversy over intoxicating hemp products. And he worries that, if things go wrong, the hemp market could shrink in “the next couple of weeks.”

Asked about recent conversations with McConnell and Rep. Andy Harris (R-MD), Paul said “We have been working diligently” with the workers “trying to reach a compromise”.

“A lot of the conversations have been constructive. They say, at least on the surface, they don’t want to get rid of it, but I think we’re kind of talking past each other,” he said.

Meanwhile, Paul recently introduced a stand-alone bill that would go in the opposite direction of the hemp ban, proposing to triple the concentration of THC that the crop could legally containaddressing several other concerns expressed by industry about federal regulations.

The senator introduced legislation in June called the Hemp Economic Mobilization Plan (HEMP) Act. It reflects versions backed up in recent sessions.

Harris, who supported the ban on THC from hemp in the House version of the agriculture spending bill, told Marijuana Moment he wasn’t worried about potential opposition to the hemp ban in the Senate—and also discussed reports on the scope his legislation would do to the industry.

The Congressional Research Service (CRS) released a report in June stating this The legislation would “effectively” ban hemp-derived cannabinoid products. It initially said the ban would also prevent the sale of CBD, but the CRS report was updated to exclude that language for unclear reasons.

The hemp language is largely consistent with the appropriations and agriculture legislation that was introduced in the last Congress, but ultimately not enacted.

Hemp industry stakeholders opposed that proposal, an earlier version of which was also included in the subcommittee’s core bill last year. is Almost identical to a provision in the 2024 Farm Bill attached by a separate committee. last May through an amendment by Rep. Mary Miller (R-IL), which also did not become law.

Further evidence of the normalization of the hemp sector, retail giant Target recently soft started sales of THC-infused drinks in select stores in minnesota

Meanwhile, the US Veterans of Foreign Wars (VFW). recently entered into its first partnership with a hemp THC beverage companyWith a brand licensing deal that will support a variety of veterans services and promote cannabis-based beverages as a potential alternative to alcohol, the beverages will be available at VFW stands across the country.

Read the full hemp survey memo below:

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Related Topics:
Continue Reading

Cannabis News

Missouri cannabis growers file class action against Good Day Farm

Published

1 hour ago

on

April 30, 2026

By

CPC of Missouri-Smithville, LLC and GF Saint Mary LLC, licensed cannabis growers and manufacturers in Missouri, filed a lawsuit in the Circuit Court of Jackson County on behalf of independent wholesalers, alleging that Good Day Farm (GDF) and its network of conspiring companies and investors were harmed by an intentional, coordinated and unconstitutional scheme. The complaint alleges that the “GDF Cartel” illegally controls or manages the state’s share of dispensary licenses and uses that market power to manipulate Missouri’s $1.52 billion cannabis market for its own profit.

GDF and its co-conspirators allegedly built the cartel by arranging for third parties to invest in limited liability companies (LLCs) that then acquire additional dispensaries, cultivation and processing facilities, all of which are owned, operated or controlled by GDF. The result: The alleged cartel exercises effective control over at least 61 dispensaries, nearly triple the 22 allowed by the Missouri Constitution, with more than 10% of dispensary licenses “under substantially common control, ownership or management.” With 224 dispensaries currently licensed statewide, the alleged GDF Cartel controls more than one in four dispensary licenses in Missouri. But its influence is even greater, with alleged Cartel dispensaries accounting for more than 40% of wholesale cannabis in the state, giving it significant — and illegal — influence over all independent growers and manufacturers forced to sell through its network.

To avoid the Missouri Constitution’s 10% licensing limit and avoid regulatory oversight, the alleged cartel operates under five different brand names:

  • Good Day Farm (21 dispensaries),
  • CODES (20 dispensaries),
  • Green light (10 dispensaries),
  • Fresh Karma (6 dispensaries), and
  • 3 Fifteen Primo (4 medications).

But they’re all part of a single, coordinated operation, the complaint says.

  • Purchase cannabis products from non-Cartel wholesalers at artificially depressed prices;
  • They supply their 61 dispensaries with the same products—mainly those produced by Cartel growers—significantly excluding products from independent wholesalers;
  • Force independent drug wholesalers to purchase the Cartel’s finished products as a condition for their wholesale products to be placed on the Cartel’s drug store shelves; and
  • Boycott non-cartel wholesalers who refuse to agree to anti-cartel demands.

Bob Hoffman, one of the attorneys leading the case, said: “The GDF Cartel is removing competition from the wholesale cannabis market and enriching itself with illegal profits through a counterproductive, clandestine business conspiracy. Missouri growers and manufacturers have been suffering under this scheme for a long time; many of them know something is wrong, but we don’t realize how the cartel has manipulated the market through this manipulation framework. Missourians to approve recreational cannabis in 2022 They voted for a fair and competitive market. Missouri licensed cannabis businesses that have suffered these practices should join us because they may be entitled to substantial damages.”

The complaint alleges the financial toll the Cartel has taken: Since the Cartel began illegal price-fixing, it has used its collective market power to lower wholesale prices by more than 20%, and continues to squeeze wholesalers and threaten the viability of their operations.

The unconstitutional complaint alleges that GDF knew its plan to build cartels could create legal risks for the company under the Constitution’s 10% licensing limit. The complaint quotes from a document provided by GDF to potential investors: “There can be no assurance that the Missouri Department of Cannabis Regulation will not dispute the number of marijuana dispensaries operated or supervised by the operator or its affiliates…”.

This action is brought on behalf of a putative class that includes all licensed independent wholesalers in Missouri that are not members of the alleged GDF Cartel for purposes of injunctive relief. Wholesalers who believe they have been financially harmed by the alleged Cartel’s practices should join the case because they may be entitled to substantial damages. The putative class is represented by the law firms of Feuerstein Kulick LLP and Bryan Cave Leighton Paisner LLP.

Source: Feuerstein Kulick LLP and Bryan Cave Leighton Paisner LLP

Continue Reading

Cannabis News

State-Licensed Marijuana Businesses Can Now Apply For Federal Protections Using New DEA Form

Published

1 hour ago

on

April 30, 2026

By

State licensee Medical marijuana companies can apply for federal protections In line with the Trump administration’s cannabis reprogramming process.

The Drug Enforcement Administration’s “Medical Marijuana Dispensary Registry Portal” went live Wednesday morning.

The move comes after the Justice Department announced that last week Marijuana Schedule I through III of the Controlled Substances Act (CSA), in stages.

Pursuant to an order signed by Attorney General Blanche, marijuana products regulated by a state medical cannabis license were immediately moved to Title III.

III. State-licensed medical cannabis dispensaries that wish to take advantage of the new legal protections and tax benefits that come with annexation status must first file an application with the DEA requesting information about their processes for storage, ordering, distribution, inventory, record keeping and other aspects of their business.

For each activity below, indicate whether the company has a standard operating procedure (SOP):

    • the order
    • receiving
    • Inventories
    • Marijuana storage
    • security
    • Distribution (including delivery services)
    • to divide
    • Destruction/Disposal
    • Reporting Theft/Loss
    • Due diligence (including provider/patient/professional verification)
    • Corresponding Liability
    • Record keeping”

The application asks about specific details of security measures such as vaults, safes, secure storage, access controls, alarm systems and on-site security personnel.

Applicants can choose whether to apply for administration of marijuana, marijuana extracts, or naturally derived delta-9 THC.

Currently, with only medical marijuana moving to Schedule III, the application asks potential registrants whether their businesses handle or provide recreational marijuana.

According to last week’s DOJ order, an expedited administrative hearing process will be held beginning June 29 to consider the broader cannabis reorganization.

The DEA application, meanwhile, also asks companies to submit information about their state’s cannabis licenses and to answer questions about their criminal and disciplinary history.

It also asks, “Has anyone involved in the ownership or operation of the business previously manufactured, distributed, and/or provided a controlled substance without a DEA registration authorizing such activity?”

Allegedly every illegal cannabis company operating in the state today has key employees who have done so, medical marijuana was a Schedule I substance whose manufacture, distribution and general distribution was not permitted by the DEA until just a few days ago.

Applicants must also list the suppliers from whom they plan to procure marijuana, and report whether they plan to repackage or relabel cannabis products.

They must also provide lists of people whose business they expect to have “access to controlled substances,” including their dates of birth, social security numbers, and drug-related criminal histories.

“Provide the following for each person you plan to acquire controlled substances:

    • The name
    • Title(s)
    • date of birth
    • Social Security number
    • DEA registration numbers, if applicable
    • State/territory permits to manufacture, distribute, dispense, or otherwise handle controlled substances
    • Has this person been subject to one or more federal, state, territorial, or tribal disciplinary actions?
    • Has this person been convicted of federal, state, territorial, tribal, or local offenses related to controlled substances?

There is also $794 per year the application fee, currently only payable through PayPal, although DEA ​​”expects to have additional payment methods in the coming weeks.”

Application fees are non-refundable.

Separately, the DEA has launched a new web page on its website that contains key information about the new federal rescheduling move for cannabis, including copies of Federal Register orders outlining the process for the amendment and the upcoming litigation.

Blanche’s reorganization order last week said that to comply with the international drug control treaty’s “requirement that a government agency act as the exclusive purchaser of cannabis production,” the DOJ is setting in motion a process by which the federal government technically buys from marijuana producers and then sells to them or related entities.

“Registered growers must store the crops in a DEA-accessible facility until that transaction is completed, and each grower’s registration must specify the area in which the grow is allowed,” he said.

“All manufacturers registered under this subsection shall establish a nominal price for the purchase of their marijuana crops. The Administration shall then purchase the entity’s crops at that price and resell the crops to the entity, or a related or supporting entity, at the same price plus the administrative fee calculated in section 1318.06(a)..”

Meanwhile, the US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after the reorganization announcement.

The reorganization will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.

White House Press Secretary Karoline Leavitt said the administration is moving forward with the marijuana overhaul because Cannabis reform is “very popular” with voters and because doing so will help people who need access to the drug for medical purposes.

At the press event held in the Oval Office last week, President Donald Trump spoke about the medical benefits of marijuana.

“A lot of people are facing big problems, and that seems to be the best answer,” he said. “They’re very happy. So the reorganization begins, and that’s a big thing, the reprogramming.”

The president stated that his administration’s rescheduling of cannabis came about after his friend Howard Kessler told him about his use of medical marijuana.

“He had some medical difficulties, and it came about by chance, kind of,” he said. “He had to go through a lot of different medications, and he said this was the one that was so much better than anything else. And so he lived through that. He didn’t benefit from it, because now he lives much better from the perspective.”

“So we hope you don’t have to,” Trump said. “But if you must, I hear it’s the best of all alternatives.”

Separately, the president asked Congress to take action changing the law that threatens to federally recriminalize hemp-derived full-spectrum CBD products later this year

“We need to do this STRAIGHT and FAST, especially for those who have found CBD helping them,” he said in a social media post. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”

A few days ago, Trump denounced this Federal officials were “slowly” pursuing his cannabis warrant.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Klasmann-Deilmann announces management changes

Published

1 day ago

on

April 29, 2026

By











After fifteen years of successful cooperation, managing director Moritz Böcking and the shareholders of Klasmann-Deilmann GmbH have mutually agreed to part ways. As of May 1, 2026, Moritz Böcking will hand over the position of managing director to Jan Astrup, who served as the company’s CEO in 2021/2022. Jan Astrup and Damian Ikemann will form the Board of Directors of the Klasmann-Deilmann Group from now on.

© Klasmann-Deilmann Benelux

Klasmann-Deilmann thanks Moritz Böcking for his cooperation and the progress achieved in the transformation of the Klasmann-Deilmann Group. Moritz Böcking expanded Klasmann-Deilmann beyond the growing media business into new areas of commercial horticulture and promoted innovation and digitalization within the company. In addition, its achievements include the expansion of resources derived from renewable raw materials, as well as the acquisition of a subsidiary in Australia and production facilities in France and Canada, which operate in cooperation with external partners. He also significantly advanced Klasmann-Deilmann’s positioning as a global pioneer of sustainable development in the growing media industry, thereby making a decisive contribution to the company’s economic growth.

With Jan Astrup, Klasmann-Deilmann is getting an internationally experienced manager who has proven himself in the company and has extensive experience in raw materials, production, process optimization and technology. With the new CEO, raw materials and technology-driven areas for the substrate industry are now increasingly important at senior management level. Jan Astrup will strengthen the core commercial horticulture business and help develop the company for the future.

For more information:
Klasmann-Deilmann GmbH
(email protected)
www.klasmann-deilmann.com



Publication date:













Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media